Author

Guy S. Salvesen

Sanford Burnham Prebys Medical Discovery InstituteORCID 0000-0002-7933-6732Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1

Frequent Co-Authors

A. ChaikuadiD· 1 shared Allison S. LimpertiD· 1 shared Betsaida Bibo‐Verdugo· 1 shared Dhanya R. Panickar· 1 shared Douglas J. SheffleriD· 1 shared Fabiana Izidro LayngiD· 1 shared Huiyu ReniD· 1 shared Jiaqian WuiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. ChaikuadORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Synthesis and Characterization of ULK1/2 Kinase Inhibitors that Inhibit Autophagy and Upregulate Expression of Major Histocompatibility Complex I for the Treatment of Non-Small Cell Lung Cancer

Fabiana Izidro Layng, Huiyu Ren, Nicole A. Bakas, Dhanya R. Panickar, Lester J. Lambert, Maria Celeridad, Jiaqian Wu, Laurent J. S. De Backer, Preeti Chandrachud, Allison S. Limpert, Mitchell Vamos, A. Chaikuad, Betsaida Bibo‐Verdugo, Patrick M. Hagan, Sonja N. Brun, , Nicholas D. P. Cosford

The paper reports the design, synthesis, and characterization of new ULK1/2 inhibitors that inhibit autophagy and upregulate MHC I in NSCLC cells, supporting their potential as cancer therapeutics.

ACS Chemical Biology · Feb 12, 2026Peer-reviewedCancer Biology